The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction

European Journal of Heart Failure

Volumn 6, Issue 5, 2004, Pages 555-560

  Cochet, Alexandre ^a   Zeller, Marianne ^b   Cottin, Yves ^b   Robert Valla, Clothilde ^a   Lalande, Alain ^a   L'Huilllier, Isabelle ^b   Comte, Alexandre ^a   Walker, Paul M ^a   Desgres, Jean ^a   Wolf, Jean Eric ^b   Brunotte, François ^a  

^a Medical University of Dijon   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Brain natriuretic peptide; Delayed CE MRI; Magnetic resonance imaging (MRI); Myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; GADOLINIUM PENTETATE; HORMONE PRECURSOR; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FIRST PASS EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEX RATIO; STATISTICAL MODEL; VENOUS BLOOD;

AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROGNOSIS;

EID: 4043074970     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.11.012     Document Type: Article

References (31)

1. Grines C.L., Browne K.F., Marco J., Rothbaum D., Stone G.W., O'Keefe J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The primary angioplasty in myocardial infarction study group. N Engl J Med. 328:1993;673-679
2. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 106:2002;2913-2918
3. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929
4. Kikuta K., Yasue H., Yoshimura M., Morita E., Sumida H., Kato H., et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J. 132:1996;101-107
5. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined - a consensus document of The European Society of Cardiology/American Society of Cardiology Committee for the redefiniton of myocardial infarction. J Am Coll Cardiol. 36:2000;959-969
6. Cottin Y., Touzery C., Guy F., Lalande A., Ressencourt O., Roy S., et al. MR imaging of the heart after myocardial infarction: effect of increasing intersection gap on measurement of left ventricular volume, ejection fraction, and wall-thickness. Radiology. 213:1999;513-520
7. Foo T.K.F., Bernstein M.A., Aisen A.M., Hernandez R.J., Collick B.D., Bernstein T. Improved ejection fraction and flow velocity estimates with use of view-sharing and uniform repetition time excitation with fast cardiac techniques. Radiology. 195:1995;471-478
8. Lauerma K., Virtanen K.S., Sipila L.M., Hekali P., Aronen H.J. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation. 96:1997;2859-2867
9. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 100:1999;1992-2002
10. Simonetti O., Kim R.J., Fieno D.S., Hillenbrand H.B., Wu E., Bundy J.M., et al. An improved MR Imaging technique for the visualisation of myocardial infarction. Radiology. 218:2001;215-223
11. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 105:2002;539-542
12. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 332:1988;78-81
13. Richards A.M., Nicholls M.G., Yandle T.G., Ikram H., Espiner E.A., Turner J.G., et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine research group. Heart. 81:1999;114-120
14. Groenning B.A., Nilsson J.C., Sondergaard L., Pedersen F., Trawinski J., Baumann M., et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J. 143:2002;923-929
15. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., Burnett J.C. Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 40:2002;976-982
16. Sayama H., Nakamura Y., Saito N., Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly patients greater than normal? Coronary Artery Dis. 10:1999;537-540
17. Nageh T., Chin D., Cooke J.C., Meehan N., Monaghan M.J., Sherwood R.A. Interpretation of plasma brain natriuretic peptide concentrations may require adjustement for patient's age. Ann Clin Biochem. 39:2002;151-153
18. Wang T.J., Larson M.G., Levy D., Leip E.P., Benjamin E.J., Wilson P.W.F., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 90:2002;254-258
19. Inoue T., Sakuma M., Yaguchi I., Mizoguchi K., Uchida T., Takayanagi K., et al. Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. Am Heart J. 143:2002;790-796
20. Groenning B.A., Nilsson J.C., Sondergaard L., Kjaer A., Larsson H.B., Hildebrandt P. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail. 3:2001;699-708
21. Talwar S., Squire I.B., Downie P.F., McCullough A.M., Campton M.C., Davies J.E., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. Eur Heart J. 21:2000;1514-1521
22. De Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:(14):2001;1014-1021
23. Crilley J.G., Farrer M. Left ventricular remodeling and brain natriuretic peptide after first myocardial infarction. Heart. 86:2001;638-642
24. Kim R.J., Chen E.L., Lima J.A., Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 94:1996;3318-3326
25. Dauber I.M., Van Benthuysen K.M., McMurtry I.F., Wheeler G.S., Lesnefsky E.J., Horwitz L.D., et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res. 66:1990;986-998
26. Saeed M., Wendland M.F., Masui T., Higgins C.B. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med. 31:1994;31-39
27. Lima J.A.C., Judd R.M., Bazille A., Schulman S.P., Atalar E., Zerhouni E.A. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation. 92:1995;1117-1125
28. Rehwald W.G., Fieno D.S., Chen E.L., Kim R.J., Judd R.M. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 105:2002;224-229
29. Rogers W.J., Kramer C.M., Geskin G., Hu Y.L., Theobald T.M., Vido D.A., et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation. 99:1999;744-750
30. Wu K.C., Zerhouni E.A., Judd R.M., Lugo-Olivieri C.H., Barouch L.A., Schulman S.P., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 97:1998;765-772
31. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., Lima J.A.C. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 106:2002;1083-1089